Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Current Leases (2018 - 2025)

Corbus Pharmaceuticals Holdings has reported Current Leases over the past 6 years, most recently at $1.4 million for Q4 2023.

  • For Q4 2023, Current Leases rose 12.19% year-over-year to $1.4 million; the TTM value through Dec 2023 reached $1.4 million, up 12.19%, while the annual FY2023 figure was $1.4 million, 12.19% up from the prior year.
  • Current Leases for Q4 2023 was $1.4 million at Corbus Pharmaceuticals Holdings, up from $1.4 million in the prior quarter.
  • Over five years, Current Leases peaked at $1.4 million in Q4 2023 and troughed at $266807.0 in Q1 2019.
  • A 5-year average of $995652.4 and a median of $1.1 million in 2021 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: soared 1555.03% in 2019 and later rose 12.19% in 2023.
  • Year by year, Current Leases stood at $595745.0 in 2019, then soared by 68.54% to $1.0 million in 2020, then grew by 13.23% to $1.1 million in 2021, then grew by 12.66% to $1.3 million in 2022, then rose by 12.19% to $1.4 million in 2023.
  • Business Quant data shows Current Leases for CRBP at $1.4 million in Q4 2023, $1.4 million in Q3 2023, and $1.4 million in Q2 2023.